Nymox Pharmaceuticals

-$0.01 (-0.74%) Today
+$0.01 (+0.75%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NYMX and other ETFs, options, and stocks.

About NYMX

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer.

CEO
Paul Averback
Employees
3
Headquarters
Nassau, New Providence
Founded
1995

NYMX Key Statistics

Market Cap
136.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
195.44K
High Today
$1.38
Low Today
$1.30
Open Price
$1.36
Volume
204.24K
52 Week High
$3.50
52 Week Low
$1.29

NYMX Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure